Alt-803 drug page Clinical trials

Trials with Alt-803

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

2Trials
0Recruiting
1Countries
5Planned patients

Showing 1–2 of 2

QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine
Finished Phase 1 2 patients NCT03563157

QUILT 3.071 NANT Colorectal Cancer (CRC) Vaccine: This is a Phase 1b/2 study investigating the effect of NANT CRC vaccine vs regorafenib in subjects with CRC who were previously treated with SOC.

United States Sept 2018 – Aug 2019 Interventional
QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer
Finished Phase 1 3 patients NCT03127098

This is a phase 1b/2 study to evaluate the safety, tolerability, and efficacy of ETBX-011 vaccine used in combination with ALT-803 in subjects with locally advanced or metastatic CEA-expressing cancers whose tumor has recurred after standa…

United States Jun 2017 – Dec 2017 Interventional
Combined with: ETBX-011